GPT Healthcare Limited's Board of Directors approved the audited financial results for the fourth quarter and financial year ended March 31, 2025, on May 23, 2025.
The Board has recommended a final dividend of 15%, i.e., ₹1.50 per equity share on the face value of ₹10 each, subject to shareholder approval at the 36th Annual General Meeting (AGM).
The dividend, if approved, will be paid within 30 days of declaration at the AGM. The record date for determining dividend entitlement is July 29, 2025.
The 36th AGM will be held on Tuesday, August 5, 2025, via Video Conferencing (VC) or Other Audio-Visual Means (OAVM).
Book closure will be from July 30, 2025, to August 5, 2025 (both days inclusive), for the AGM.
Mr. Ashok Kumar Daga, Company Secretary in Practice, has been appointed as the Secretarial Auditor for five consecutive years, starting from FY26 until FY30, subject to shareholder approval.
The board recommended the continuation of Mr. Kashi Prasad Khandelwal as a Non-Executive Independent Director, even after attaining 75 years of age, subject to shareholder approval.
Variation in terms of reappointment of Mr. Dwarika Prasad Tantia, Executive Chairman and Mr. Anurag Tantia, Executive Director has been approved, subject to shareholder approval.
Payment of Doctor Consultancy Fees to Dr. Aruna Tantia and Dr. Ghanshyam Goyal, Non-Executive Non-Independent Directors, has been approved, subject to shareholder approval.
S.K. Sahu & Associates has been reappointed as the Cost Auditors for FY26, subject to ratification of their remuneration by shareholders.
RSM Astute Consulting Private Limited and ARVS & Associates have been appointed/reappointed as Internal Auditors for FY26.
The Risk Management Committee has been dissolved as the provision of Regulation 21(5) of LODR is not applicable to the company.
S R Batliboi & Co LLP, Chartered Accountants, have issued an audit report with an unmodified opinion on the audited financial results.
Revenue from operations for the year ended March 31, 2025 stood at ₹40,709.14 lakhs as compared to ₹40,015.30 lakhs in the previous year.
Total Income for the year ended March 31, 2025 stood at ₹41,558.57 lakhs.
Profit after tax for the year ended March 31, 2025 stood at ₹4,992.17 lakhs.
The Board of Directors have proposed final dividend @ 15% i.e: ₹ 1.50 per Equity share, subject to approval of the shareholders at the ensuing Annual General Meeting. The Company has paid interim dividend @ 10% i.e; ₹ 1 per Equity share for financial year 2024-25. Total dividend including interim dividend for the financial year 2024-25 is ₹ 2.50 per Equity share on face value of ₹ 10 per share.